Literature DB >> 5148984

Interaction of personality and treatment conditions associated with success in a smoking control program.

M A Jacobs, A Z Spilken, M M Norman, G W Wohlberg, P H Knapp.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5148984     DOI： 10.1097/00006842-197111000-00007

Source DB:  PubMed          Journal:  Psychosom Med        ISSN： 0033-3174            Impact factor:   4.312


× No keyword cloud information.
  10 in total

1.  Five year follow-up of a smoking withdrawal clinic population.

Authors:  D W West; S Graham; M Swanson; G Wilkinson
Journal:  Am J Public Health       Date:  1977-06       Impact factor: 9.308

2.  Clinical methods in smoking cessation: description and evaluation of a stop smoking clinic.

Authors:  T Harrup; B A Hansen; K Soghikian
Journal:  Am J Public Health       Date:  1979-12       Impact factor: 9.308

Review 3.  Lobeline for smoking cessation.

Authors:  Lindsay F Stead; John R Hughes
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 4.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Smoking reduction interventions for smoking cessation.

Authors:  Nicola Lindson; Elias Klemperer; Bosun Hong; José M Ordóñez-Mena; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-09-30

6.  Antidepressants for smoking cessation.

Authors:  Seth Howes; Jamie Hartmann-Boyce; Jonathan Livingstone-Banks; Bosun Hong; Nicola Lindson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-22

Review 7.  Why are Antidepressant Drugs Effective Smoking Cessation Aids?

Authors:  Mohammed Shoaib; Yazead Buhidma
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 8.  Antidepressants for smoking cessation.

Authors:  John R Hughes; Lindsay F Stead; Jamie Hartmann-Boyce; Kate Cahill; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2014-01-08

Review 9.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

10.  Investigating drug repositioning opportunities in FDA drug labels through topic modeling.

Authors:  Halil Bisgin; Zhichao Liu; Reagan Kelly; Hong Fang; Xiaowei Xu; Weida Tong
Journal:  BMC Bioinformatics       Date:  2012-09-11       Impact factor: 3.169
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.